PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Journal article

Peer reviewed

N.F. Larusso, C.L. Bowlus, C. Levy, R. Vuppalanchi, A. Floreani, P. Andreone, R. Srestha, J. Trotter, D. Goldberg, S. Rushbrook, …

Digestive and liver disease, Vol.50(2), pp.e67-e67

2018-03

Metrics

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.151 Pancreas & Gall Bladder Disorders; 1.151.760 Bile Acids
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: PC.01.8 THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Creators: N.F. Larusso
C.L. Bowlus
C. Levy
R. Vuppalanchi
A. Floreani
P. Andreone
R. Srestha
J. Trotter
D. Goldberg
S. Rushbrook
G.M. Hirschfield
C. Van Biene
R. Penceck
L. Macconell
S. David
Publication Details: Digestive and liver disease, Vol.50(2), pp.e67-e67
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
Record Identifier: 991031714253002976